Amiodarone-induced vortex keratopathy at a low maintenance dose

  • Deepti Mahajan Senior resident ophthalmology
  • Anil Verma
  • Rajesh Sharma
Keywords: amiodarone, keratopathy, vortex


Vortex keratopathy is a common side effect of amiodarone, which is a class III antiarrhythmic agent. We describe a 50-year-old man who developed vortex keratopahy with amiodarone 200 mg BD for atrial fibrillation since two years. The daily (400 mg/day) and cumulative dose (100 g) combined with the length of therapy is associated with the toxicity. Toxic effects may also be observed at lower maintenance doses, as observed in this patient. This case indicates that multi-organ toxicity due to amiodarone may develop even with short-term use and a low maintenance dose. Having been off the medication for two months, it is expected that the deposition pattern will diminish, as is the case for the vast majority of patients.


Gittinger JW, Jr, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol. 1987;105:349-351.

Hollander DA, Aldave AJ. Drug-induced corneal complications. Curr Opin Ophthalmol. 2004;15:541-548.

D’Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol. 1981;99:257-261.

Flach AJ, Dolan BJ, Sudduth B, Weddell J. Amiodarone-induced lens opacities. Arch Ophthalmol. 1983;101:1554-1556.

Uçakhan OO, Kanpolat A, Ylmaz N, Ozkan M. Amiodarone keratopathy: an in vivo confocal microscopy study. Eye Contact Lens. 2005;31:148-157.

How to Cite
Mahajan, D., Verma, A., & Sharma, R. (2020). Amiodarone-induced vortex keratopathy at a low maintenance dose. Asian Journal of Ophthalmology, 17(2), 170-172.
Case Reports/Case Series